BioBots to Bring Revolutionary 3D Bioprinter to the Masses with $5,000 Beta Program & Eventually Print Whole Organs
News
GenPro presents azacitidine efficacy study to identify epigenetic predictors of Responder vs Non-Responder AML/MDS patients
GenPro publishes EpiMarker feasibility study revealing distinct epigenetic signature of Parkinson’s Disease in blood
Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms